TP53 and invasive carcinoma: The frequency of p53-related lesions in the healthy controls and in the high-risk population without BRCA1/2 gene mutation was comparable to that of BRCA carriers, but to date, the data show no progression towards HGSC; no STIC or invasive carcinoma was reported in either group.